In addition, TRIP13 was found to be involved in the activation of AKT/mTOR, Wnt/β-catenin and TGF-β1/SMAD3 signalling pathways to promote the proliferation and metastasis of tumours [16, 18, 19]. Here, TRIP13 is linked to neoplasm.